Release Date: 30/04/10 16:03 Summary: Appendix 4C - quarterly Price Sensitive: No Download Document 303.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%